A citation-based method for searching scientific literature

Tatiane Yanes, Amanda M Willis, Bettina Meiser, Katherine M Tucker, Megan Best. Eur J Hum Genet 2019
Times Cited: 30







List of co-cited articles
123 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
259
23

Genomic testing in cancer: patient knowledge, attitudes, and expectations.
Phillip S Blanchette, Anna Spreafico, Fiona A Miller, Kelvin Chan, Jessica Bytautas, Steve Kang, Philippe L Bedard, Andrea Eisen, Larissa Potanina, Jack Holland,[...]. Cancer 2014
58
16

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.
Nadine A Kasparian, Bettina Meiser, Phyllis N Butow, Judy M Simpson, Graham J Mann. Genet Med 2009
67
16

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
902
13

Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study.
R Liang, B Meiser, S Smith, N A Kasparian, C R Lewis, M Chin, G V Long, R Ward, A M Menzies, J N Harris-Wai,[...]. Eur J Cancer Care (Engl) 2017
14
28

Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancers.
Subotheni Thavaneswaran, Lucille Sebastian, Mandy Ballinger, Megan Best, Dominique Hess, Chee K Lee, Katrin M Sjoquist, Wendy E Hague, Phyllis N Butow, R John Simes,[...]. Med J Aust 2018
19
21

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
Stacy W Gray, Katherine Hicks-Courant, Christopher S Lathan, Levi Garraway, Elyse R Park, Jane C Weeks. J Oncol Pract 2012
82
13

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
166
13

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Shoshana M Rosenberg, Michaela S Tracy, Meghan E Meyer, Karen Sepucha, Shari Gelber, Judi Hirshfield-Bartek, Susan Troyan, Monica Morrow, Lidia Schapira, Steven E Come,[...]. Ann Intern Med 2013
189
13

Patient satisfaction with health care decisions: the satisfaction with decision scale.
M Holmes-Rovner, J Kroll, N Schmitt, D R Rovner, M L Breer, M L Rothert, G Padonu, G Talarczyk. Med Decis Making 1996
405
13

A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Amelia K Smit, David Espinoza, Ainsley J Newson, Rachael L Morton, Georgina Fenton, Lucinda Freeman, Kate Dunlop, Phyllis N Butow, Matthew H Law, Michael G Kimlin,[...]. Cancer Epidemiol Biomarkers Prev 2017
29
10


Challenges in the clinical application of whole-genome sequencing.
Kelly E Ormond, Matthew T Wheeler, Louanne Hudgins, Teri E Klein, Atul J Butte, Russ B Altman, Euan A Ashley, Henry T Greely. Lancet 2010
157
10

The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.
Megan Best, Ainsley J Newson, Bettina Meiser, Ilona Juraskova, David Goldstein, Kathy Tucker, Mandy L Ballinger, Dominique Hess, Timothy E Schlub, Barbara Biesecker,[...]. BMC Cancer 2018
9
33

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur J Hum Genet 2014
65
10

Theories for Psychotherapeutic Genetic Counseling: Fuzzy Trace Theory and Cognitive Behavior Theory.
Barbara Biesecker, Jehannine Austin, Colleen Caleshu. J Genet Couns 2017
14
21


The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
Megan Best, Ainsley J Newson, Bettina Meiser, Ilona Juraskova, David Goldstein, Kathy Tucker, Mandy L Ballinger, Dominique Hess, Timothy E Schlub, Barbara Biesecker,[...]. BMC Cancer 2018
11
27

Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact.
Erna Claes, Lieve Denayer, Gerry Evers-Kiebooms, Andrea Boogaerts, Eric Legius. Patient Educ Couns 2004
63
10

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
994
10


Patient perspectives on molecular tumor profiling: "Why wouldn't you?"
Megan C Best, Nicole Bartley, Chris Jacobs, Ilona Juraskova, David Goldstein, Ainsley J Newson, Jacqueline Savard, Bettina Meiser, Mandy Ballinger, Christine Napier,[...]. BMC Cancer 2019
15
20

Association analysis identifies 65 new breast cancer risk loci.
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
549
10

Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Mary-Anne Young, Laura Elenor Forrest, Victoria-Mae Rasmussen, Paul James, Gillian Mitchell, Sarah Dilys Sawyer, Katrina Reeve, Nina Hallowell. J Genet Couns 2018
17
17

Behavioral and psychosocial responses to genomic testing for colorectal cancer risk.
Kristi D Graves, Kara-Grace Leventhal, Rachel Nusbaum, Yasmin Salehizadeh, Gillian W Hooker, Beth N Peshkin, Morgan Butrick, William Tuong, Jeena Mathew, David Goerlitz,[...]. Genomics 2013
23
13

Clinical use of current polygenic risk scores may exacerbate health disparities.
Alicia R Martin, Masahiro Kanai, Yoichiro Kamatani, Yukinori Okada, Benjamin M Neale, Mark J Daly. Nat Genet 2019
572
10

A role for common genomic variants in the assessment of familial breast cancer.
Sarah Sawyer, Gillian Mitchell, Joanne McKinley, Georgia Chenevix-Trench, Jonathan Beesley, Xiao Qing Chen, David Bowtell, Alison H Trainer, Marion Harris, Geoffrey J Lindeman,[...]. J Clin Oncol 2012
57
10

The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
D Gareth Evans, Adam Brentnall, Helen Byers, Elaine Harkness, Paula Stavrinos, Anthony Howell, William G Newman, Jack Cuzick. J Med Genet 2017
37
10

The emerging field of polygenic risk scores and perspective for use in clinical care.
Tatiane Yanes, Aideen M McInerney-Leo, Matthew H Law, Shelly Cummings. Hum Mol Genet 2020
15
20

"It's not like judgment day": public understanding of and reactions to personalized genomic risk information.
Erynn S Gordon, Georgia Griffin, Lisa Wawak, Hauchie Pang, Sarah E Gollust, Barbara A Bernhardt. J Genet Couns 2012
47
6

Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study.
Katherine Wasson, Tonya Nashay Sanders, Nancy S Hogan, Sara Cherny, Kathy J Helzlsouer. J Community Genet 2013
23
8

Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.
Karen Glanz, Kathryn Volpicelli, Peter A Kanetsky, Michael E Ming, Lynn M Schuchter, Christopher Jepson, Susan M Domchek, Katrina Armstrong. Cancer Epidemiol Biomarkers Prev 2013
28
7

Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.
Johanna Ringwald, Christina Wochnowski, Kristin Bosse, Katrin Elisabeth Giel, Norbert Schäffeler, Stephan Zipfel, Martin Teufel. J Genet Couns 2016
48
6

Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?
A K Smit, L A Keogh, A J Newson, P N Butow, K Dunlop, R L Morton, J Kirk, D Espinoza, A E Cust. Br J Dermatol 2017
13
15


Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
65
6

Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis.
Kelly F J Stewart, Anke Wesselius, Maartje A C Schreurs, Annemie M W J Schols, Maurice P Zeegers. J Community Genet 2018
35
6

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.
Jeanna M McCuaig, Susan Randall Armel, Melanie Care, Alexandra Volenik, Raymond H Kim, Kelly A Metcalfe. Cancers (Basel) 2018
40
6

Characterizing Participants in the ClinSeq Genome Sequencing Cohort as Early Adopters of a New Health Technology.
Katie L Lewis, Paul K J Han, Gillian W Hooker, William M P Klein, Leslie G Biesecker, Barbara B Biesecker. PLoS One 2015
36
6

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.
Shelly S Lo, Patricia B Mumby, John Norton, Karen Rychlik, Jeffrey Smerage, Joseph Kash, Helen K Chew, Ellen R Gaynor, Daniel F Hayes, Andrew Epstein,[...]. J Clin Oncol 2010
231
6

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
6

Physicians' attitudes about multiplex tumor genomic testing.
Stacy W Gray, Katherine Hicks-Courant, Angel Cronin, Barrett J Rollins, Jane C Weeks. J Clin Oncol 2014
151
6

Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.
Andrew J Epstein, Yu-Ning Wong, Nandita Mitra, Anil Vachani, Sakhena Hin, Lin Yang, Aaron Smith-McLallen, Katrina Armstrong, Peter W Groeneveld. J Clin Oncol 2015
19
10

The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.
Jason L Vassy, Kurt D Christensen, Erica F Schonman, Carrie L Blout, Jill O Robinson, Joel B Krier, Pamela M Diamond, Matthew Lebo, Kalotina Machini, Danielle R Azzariti,[...]. Ann Intern Med 2017
107
6

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
76
6


ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
6



Keeping Expectations in Check With Immune Checkpoint Inhibitors.
Jennifer S Temel, Justin F Gainor, Ryan J Sullivan, Joseph A Greer. J Clin Oncol 2018
33
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.